Cargando…

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

BACKGROUND: Patients with liver cirrhosis have been excluded from randomized clinical trials of oral anticoagulation therapy for stroke prevention in atrial fibrillation. We hypothesized that patients with liver cirrhosis would have a positive net clinical benefit for oral anticoagulation when used...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kuo, Ling, Chao, Tze‐Fan, Liu, Chia‐Jen, Lin, Yenn‐Jiang, Chang, Shih‐Lin, Lo, Li‐Wei, Hu, Yu‐Feng, Tuan, Ta‐Chuan, Liao, Jo‐Nan, Chung, Fa‐Po, Chen, Tzeng‐Ji, Lip, Gregory Y. H., Chen, Shih‐Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5669162/ https://www.ncbi.nlm.nih.gov/pubmed/28645935 http://dx.doi.org/10.1161/JAHA.116.005307

Ejemplares similares

Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA(2)DS(2)‐VASc Score of 1 (Men) or 2 (Women)?
por: Hung, Yuan, et al.
Publicado: (2016)

Oral anticoagulant use for stroke prevention in atrial fibrillation patients with difficult scenarios
por: Chang, Ting-Yung, et al.
Publicado: (2018)

Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non–vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage
por: Tsai, Chuan-Tsai, et al.
Publicado: (2020)

Shared decision making for anticoagulation reduces anxiety and improves adherence in patients with atrial fibrillation
por: Chiu, Hsiao-Hui, et al.
Publicado: (2023)

European Society of Cardiology Guideline-Adherent Antithrombotic Treatment and Risk of Mortality in Asian Patients with Atrial Fibrillation
por: Li, Cheng-Hung, et al.
Publicado: (2016)

Focal atrial fibrillation presenting in the origin of atrial tachycardia
por: Lin, Chin-Yu, et al.
Publicado: (2015)

Risk and Prediction of Sudden Cardiac Death and Ventricular Arrhythmias for Patients with Atrial Fibrillation – A Nationwide Cohort Study
por: Chao, Tze-Fan, et al.
Publicado: (2017)

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients without previous oral anticoagulants or stable under warfarin: a nationwide cohort study
por: Liu, Shin-Huei, et al.
Publicado: (2023)

Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram
por: Chao, Tze-Fan, et al.
Publicado: (2013)

Clinical outcomes and structural remodelling after ablation of atrial fibrillation in heart failure with mildly reduced or mid‐range ejection fraction
por: Lee, Dan‐Ying, et al.
Publicado: (2022)

Catheter Ablation of Ventricular Tachycardia/Fibrillation in a Patient with Right Ventricular Amyloidosis with Initial Manifestations Mimicking Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
por: Chung, Fa-Po, et al.
Publicado: (2017)

Applying the CHA(2)DS(2)-VASc score to predict the risk of future acute coronary syndrome in patients receiving catheter ablation for atrial fibrillation
por: Chou, Ching-Yao, et al.
Publicado: (2020)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Long-term outcome of patients with long-standing persistent atrial fibrillation undergoing ablation guided by a novel high-density panoramic mapping system: A propensity score matching study
por: Chang, Ting-Yung, et al.
Publicado: (2022)

The Accuracy and Clinical Applicability of a Sensor Based Electromagnetic Non-fluoroscopic Catheter Tracking System
por: Yamada, Shinya, et al.
Publicado: (2018)

Catheter ablation in Asian patients with atrial fibrillation and hypertrophic cardiomyopathy: electrophysiological characteristics of recurrence and long-term clinical outcomes
por: Lin, Chih-Hsien, et al.
Publicado: (2023)

ABO Blood Groups as a Disease Marker to Predict Atrial Fibrillation Recurrence after Catheter Ablation
por: Liu, Shin-Huei, et al.
Publicado: (2023)

The Association between Heme Oxygenase-1 Gene Promoter Polymorphism and the Outcomes of Catheter Ablation of Atrial Fibrillation
por: Hu, Yu-Feng, et al.
Publicado: (2013)

Catheter Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy
por: Chung, Fa-Po, et al.
Publicado: (2018)

Fractal complexity alternations in paroxysmal atrial fibrillation patients with and without recurrence after pulmonary vein isolation
por: Liao, Ting‐Wei Ernie, et al.
Publicado: (2023)

The application of novel segmentation software to create left atrial geometry for atrial fibrillation ablation: The implication of spatial resolution
por: Chin, Chye-Gen, et al.
Publicado: (2020)

Ablation of atrial fibrillation and dementia risk reduction during long-term follow-up: a nationwide population-based study
por: Li, Guan-Yi, et al.
Publicado: (2023)

Clinical Risk Score for the Prediction of Incident Atrial Fibrillation: Derivation in 7 220 654 Taiwan Patients With 438 930 Incident Atrial Fibrillations During a 16‐Year Follow‐Up
por: Chao, Tze‐Fan, et al.
Publicado: (2021)

Different Renal Function Equations and Dosing of Direct Oral Anticoagulants in Atrial Fibrillation
por: Chan, Yi-Hsin, et al.
Publicado: (2022)

Catheter Ablation With Morphologic Repetitiveness Mapping for Persistent Atrial Fibrillation
por: Lin, Chin-Yu, et al.
Publicado: (2023)

Atrial fibrillation as a contributor to the mortality in patients with dementia: A nationwide cohort study
por: Chen, Yun-Yu, et al.
Publicado: (2023)

Novel model-based point scoring system for predicting stroke risk in atrial fibrillation patients: Results from a nationwide cohort study with validation
por: Chen, Yun-Yu, et al.
Publicado: (2021)

Presence of diabetic microvascular complications does not incrementally increase risk of ischemic stroke in diabetic patients with atrial fibrillation: A nationwide cohort study
por: Chou, Annie Y., et al.
Publicado: (2016)

Epicardial electrical heterogeneity after amiodarone treatment increases vulnerability to ventricular arrhythmias under therapeutic hypothermia
por: Lin, Chin-Yu, et al.
Publicado: (2023)

Optimal substrate modification strategies using catheter ablation in patients with persistent atrial fibrillation: 3‐year follow‐up outcomes
por: Hsieh, Yu‐Cheng, et al.
Publicado: (2021)

Epicardial Adipose Tissue Thickness and Ablation Outcome of Atrial Fibrillation
por: Chao, Tze-Fan, et al.
Publicado: (2013)

Alteration of Skin Sympathetic Nerve Activity after Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation
por: Sung, Wei-Ting, et al.
Publicado: (2022)

Anticoagulation in patients with atrial fibrillation and liver cirrhosis
por: Karapedi, Eleni, et al.
Publicado: (2022)

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation
por: Chang, Po-Yin, et al.
Publicado: (2021)

Intramural Reentrant Ventricular Tachycardia in a Patient with Severe Hypertensive Left Ventricular Hypertrophy
por: Lin, Chin-Yu, et al.
Publicado: (2015)

Can Genetic Risk Scoring Predict Atrial Fibrillation Ablation Outcomes?
por: Lin, Chin-Yu, et al.
Publicado: (2019)

Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians
por: Suenari, Kazuyoshi, et al.
Publicado: (2017)

Prognostic Significance of Premature Atrial Complexes Burden in Prediction of Long-Term Outcome
por: Lin, Chin-Yu, et al.
Publicado: (2015)

Ventricular arrhythmias in nonischemic cardiomyopathy
por: Chung, Fa‐Po, et al.
Publicado: (2018)

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation
por: Simon, Tracey G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o19qcqr2h1idl9ou8nf7743b1m